1. Home
  2. FGEN vs MOBX Comparison

FGEN vs MOBX Comparison

Compare FGEN & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MOBX
  • Stock Information
  • Founded
  • FGEN 1993
  • MOBX 2020
  • Country
  • FGEN United States
  • MOBX United States
  • Employees
  • FGEN N/A
  • MOBX N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MOBX
  • Sector
  • FGEN Health Care
  • MOBX
  • Exchange
  • FGEN Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • FGEN 33.5M
  • MOBX 34.2M
  • IPO Year
  • FGEN 2014
  • MOBX N/A
  • Fundamental
  • Price
  • FGEN $5.55
  • MOBX $0.75
  • Analyst Decision
  • FGEN Strong Buy
  • MOBX
  • Analyst Count
  • FGEN 1
  • MOBX 0
  • Target Price
  • FGEN $250.00
  • MOBX N/A
  • AVG Volume (30 Days)
  • FGEN 60.2K
  • MOBX 229.0K
  • Earning Date
  • FGEN 08-05-2025
  • MOBX 08-13-2025
  • Dividend Yield
  • FGEN N/A
  • MOBX N/A
  • EPS Growth
  • FGEN N/A
  • MOBX N/A
  • EPS
  • FGEN N/A
  • MOBX N/A
  • Revenue
  • FGEN $6,996,000.00
  • MOBX $10,692,000.00
  • Revenue This Year
  • FGEN N/A
  • MOBX N/A
  • Revenue Next Year
  • FGEN N/A
  • MOBX N/A
  • P/E Ratio
  • FGEN N/A
  • MOBX N/A
  • Revenue Growth
  • FGEN N/A
  • MOBX 450.28
  • 52 Week Low
  • FGEN $4.50
  • MOBX $0.55
  • 52 Week High
  • FGEN $38.25
  • MOBX $2.47
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 37.88
  • MOBX 53.45
  • Support Level
  • FGEN $4.85
  • MOBX $0.72
  • Resistance Level
  • FGEN $5.70
  • MOBX $0.84
  • Average True Range (ATR)
  • FGEN 0.56
  • MOBX 0.09
  • MACD
  • FGEN -0.03
  • MOBX 0.01
  • Stochastic Oscillator
  • FGEN 28.75
  • MOBX 39.10

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: